Author:
Benitez Fuentes Javier David
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer;Forde PM;N Engl J Med,2022
2. Perioperative pembrolizumab for early-stage non-Small-cell lung cancer;Wakelee H;N Engl J Med,2023
3. Perioperative nivolumab and chemotherapy in stage III non-small-cell lung cancer;Provencio M;N Engl J Med,2023
4. Perioperative durvalumab for resectable non-small-cell lung cancer;Heymach JV;N Engl J Med,2023
5. Cancer Clinical Trial Eligibility Criteria. Patients with HIV, Hepatitis B Virus, or Hepatitis C Virus Infections. (2020). Accessed: December 16, 2023: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cancer-clinical-trial-eligibility-criteria-p....